{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T07:51:44Z","timestamp":1792396304263,"version":"4.4.0"},"update-to":[{"DOI":"10.1002\/14651858.cd004692.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T00:00:00Z","timestamp":1637712000000}}],"reference-count":274,"publisher":"Wiley","issue":"11","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd004692.pub5","type":"journal-article","created":{"date-parts":[[2021,11,26]],"date-time":"2021-11-26T03:20:03Z","timestamp":1637896803000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Omega-3 fatty acids for depression in adults"],"prefix":"10.1002","volume":"2021","author":[{"given":"Katherine M","family":"Appleton","sequence":"additional","affiliation":[{"name":"Department of Psychology; Bournemouth University; Poole UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D","family":"Voyias","sequence":"additional","affiliation":[{"name":"North Bristol NHS Trust; Bristol UK"},{"name":"University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah M","family":"Sallis","sequence":"additional","affiliation":[{"name":"Centre for Academic Mental Health, Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"},{"name":"MRC Integrative Epidemiology Unit (IEU) at the University of Bristol; Bristol UK"},{"name":"School of Psychological Science; University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dawson","sequence":"additional","affiliation":[{"name":"Population Health Sciences, Bristol Medical School; University of Bristol; Bristol UK"},{"name":"Cochrane Common Mental Disorders; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew R","family":"Ness","sequence":"additional","affiliation":[{"name":"NIHR Bristol Biomedical Research Centre; University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Churchill","sequence":"additional","affiliation":[{"name":"Cochrane Common Mental Disorders; University of York; York UK"},{"name":"Centre for Reviews and Dissemination; University of York; York UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Perry","sequence":"additional","affiliation":[{"name":"NIHR Bristol Biomedical Research Centre; University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol; Bristol UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,11,24]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1159\/000321804","article-title":"Supplementation with eicosapentaenoic omega-3 fatty acid does not influence serum brain-derived neurotrophic factor in diabetes mellitus patients with major depression: a randomized controlled pilot study","volume":"63","author":"Bot","year":"2011","journal-title":"Neuropsychobiology"},{"issue":"1-2","key":"10.1002\/14651858.CD004692.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jad.2010.04.008","article-title":"Eicosapentaenoic acid as an add-on to antidepressant medication for co-morbid major depression in patients with diabetes mellitus: a randomized, double-blind placebo-controlled study [ISRCTN30877831; NTR624]","volume":"126","author":"Bot","year":"2010","journal-title":"Journal of Affective Disorders"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"e49431","DOI":"10.1371\/journal.pone.0049431","article-title":"Biological effects of add-on eicosapentaenoic acid supplementation in diabetes mellitus and co-morbid depression: a randomized controlled trial","volume":"7","author":"Mocking","year":"2012","journal-title":"PloS ONE"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0004|cit4","unstructured":"Pouwer F Addition of eicosapentaenoic acid to maintenance anti-depressant therapy in diabetes patients with major depressive disorder: a double-blind, placebo-controlled pilot study www.controlled-trials.com\/ISRCTN30877831"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub5-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/01.NT.0000303363.61251.8f","article-title":"News breaks","volume":"44","year":"2009","journal-title":"Nutrition Today"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub5-BIB0006|cit6","first-page":"523","article-title":"Use of omega-3 with treatment for depression in heart disease patients may not provide benefit","volume":"7","year":"2009","journal-title":"Nurse Prescribing"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jpsychores.2010.11.006","article-title":"Inflammation and treatment response to sertraline in patients with coronary heart disease and comorbid major depression","volume":"71","author":"Bot","year":"2011","journal-title":"Journal of Psychosomatic Research"},{"issue":"15","key":"10.1002\/14651858.CD004692.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jama.2009.1487","article-title":"Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: A randomized controlled trial [NCT00116857]","volume":"302","author":"Carney","year":"2009","journal-title":"JAMA"},{"issue":"9","key":"10.1002\/14651858.CD004692.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jama.2010.191","article-title":"'Omega-3 fatty acids for CHD with depression': Reply to comment","volume":"303","author":"Carney","year":"2010","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.4088\/JCP.14m09660","article-title":"Baseline Blood Levels of Omega-3 and Depression Remission: A secondary analysis of data from a placebo-controlled trial of omega-3 supplements","volume":"77","author":"Carney","year":"2016","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0011|cit11","unstructured":"Carney RM Omega-3 fatty acids to improve depression and reduce cardiovascular risk factors ClinicalTrials.gov\/show\/NCT00116857"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1753-4887.2009.00263.x","article-title":"Nutrition updates","volume":"68","author":"D'Anci","year":"2010","journal-title":"Nutrition Reviews"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4088\/JCP.10m06455","article-title":"Obstructive sleep apnea\/hypopnea syndrome and poor response to sertraline in patients with coronary heart disease","volume":"73","author":"Roest","year":"2012","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0014|cit14","unstructured":"EPA with antidepressant did not improve treatment efficacy in cardiac patients Brown University Psychopharmacology Update 2019 Sept"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0015|cit15","first-page":"19m12742","article-title":"A randomized placebo-controlled trial of Omega-3 and sertraline in depressed patients with or at risk for coronary heart disease","volume":"80","author":"Carney","year":"2019","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0016|cit16","unstructured":"Omega-3 for depression and other cardiac risk factors - 2 (Omega-3(2)) clinicaltrials.gov\/ct2\/show\/NCT02021669"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0017|cit17","first-page":"S11","article-title":"A double blind-placebo controlled trial of omega-3 polyunsaturated fatty acids (n-3 PUFAs) in patients with cardiovascular diseases (CVDs) and comorbid major depressive disorder (MDD)","volume":"21","author":"Chang","year":"2018","journal-title":"Nutritional Neuroscience"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbi.2019.03.012","article-title":"Omega-3 polyunsaturated fatty acids in cardiovascular diseases comorbid major depressive disorder - Results from a randomized controlled trial","volume":"85","author":"Chang","year":"2020","journal-title":"Brain, Behavior, and Immunity"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0019|cit19","unstructured":"Omega-3 polyunsaturated fatty acids on major depressive disorder in patients with cardiovascular diseases NCT03072823"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0020|cit20","unstructured":"Coryell WH Essential fatty acids for major depression ClinicalTrials.gov\/show\/NCT00256412"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0021|cit21","first-page":"157","article-title":"Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram","volume":"22","author":"Fiedorowicz","year":"2010","journal-title":"Annals of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0022|cit22","unstructured":"Coryell WH Essential fatty acids for major depression ClinicalTrials.gov\/show\/NCT00256412"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0023|cit23","first-page":"157","article-title":"Neuroticism but not omega-3 fatty acid levels correlate with early responsiveness to escitalopram","volume":"22","author":"Fiedorowicz","year":"2010","journal-title":"Annals of Clinical Psychiatry"},{"issue":"2-3","key":"10.1002\/14651858.CD004692.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"Da Silva","year":"2008","journal-title":"Journal of Affective Disorders"},{"issue":"2-3","key":"10.1002\/14651858.CD004692.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jad.2008.03.008","article-title":"Depression in Parkinson's disease: a double-blind, randomized, placebo-controlled pilot study of omega-3 fatty-acid supplementation","volume":"111","author":"Da Silva","year":"2008","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/JCP.0b013e31823f3b5f","article-title":"Omega-3 fatty acid augmentation of citalopram treatment for patients with major depressive disorder","volume":"32","author":"Gertsik","year":"2012","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0027|cit27","unstructured":"Gertsik L PUFA augmentation in treatment of major depression ClinicalTrials.gov\/show\/NCT00067301"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/MJT.0000000000000078","article-title":"Effects of omega-3 fatty acids on depression and quality of life in maintenance hemodialysis patients","volume":"21","author":"Dashti-Khavidaki","year":"2014","journal-title":"American Journal of Therapeutics"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2008-2231-22-11","article-title":"Potential effects of omega-3 fatty acids on anemia and inflammatory markers in maintenance hemodialysis patients","volume":"22","author":"Gharekhani","year":"2014","journal-title":"DARU"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s00228-014-1666-1","article-title":"The effect of omega-3 fatty acids on depressive symptoms and inflammatory markers in maintenance hemodialysis patients: a randomized, placebo-controlled clinical trial","volume":"70","author":"Gharekhani","year":"2014","journal-title":"European Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0031|cit31","unstructured":"Evaluating therapeutic effects of omega-3 fatty acids on anemia and nutritional status in hemodialysis patients with depression en.irct.ir\/trial\/3051"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0032|cit32","first-page":"72","article-title":"Omega-3 fatty acids as adjunctive of antidepressant therapy and its effects on brain-derived neurotrophic factor in serum, monocytes and lymphocytes","volume":"30","author":"Gonzalez","year":"2011","journal-title":"Archivos Venezolanos de Farmacologia y Terapeutica"},{"issue":"7","key":"10.1002\/14651858.CD004692.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.pnpbp.2007.06.004","article-title":"Fish oil supplementation in the treatment of major depression: a randomised double-blind placebo-controlled trial","volume":"31","author":"Grenyer","year":"2007","journal-title":"Progress in Neuro-psychopharmacology & Biological Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD004692.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s11745-013-3801-7","article-title":"Improvement of major depression is associated with increased erythrocyte DHA","volume":"48","author":"Meyer","year":"2013","journal-title":"Lipids"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0035|cit35","first-page":"30","article-title":"Fish oil not effective for chronic refractory depression","volume":"13","author":"Rotblatt","year":"2008","journal-title":"Focus on Alternative & Complementary Therapies"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0036|cit36","unstructured":"Effect of omega-3-fatty acids versus placebo on clinical symptoms of patients with major depressive disorder Irct201705249014N"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jpsychires.2018.09.016","article-title":"Influence of adjuvant omega-3-polyunsaturated fatty acids on depression, sleep, and emotion regulation among outpatients with major depressive disorders - results from a double-blind, randomized and placebo-controlled clinical trial","volume":"107","author":"Jahangard","year":"2018","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.psychres.2009.04.013","article-title":"Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder","volume":"178","author":"Jazayeri","year":"2010","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00048670701827275","article-title":"Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder","volume":"42","author":"Jazayeri","year":"2008","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.psychres.2009.04.013","article-title":"Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder","volume":"178","author":"Jazayeri","year":"2010","journal-title":"Psychiatry Research"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1080\/00048670701827275","article-title":"Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder","volume":"42","author":"Jazayeri","year":"2008","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jchf.2018.03.011","article-title":"Long-chain omega-3 fatty acid supplements in depressed heart failure patients: results of the OCEAN trial","volume":"6","author":"Jiang","year":"2018","journal-title":"JACC Heart Failure"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0043|cit43","unstructured":"Omega 3 for treatment of depression in patients with heart failure (OCEAN) clinicaltrials.gov\/ct2\/show\/NCT02057406"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jchf.2018.03.011","article-title":"Long-chain omega-3 fatty acid supplements in depressed heart failure patients: results of the OCEAN trial","volume":"6","author":"Jiang","year":"2018","journal-title":"JACC Heart Failure"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0045|cit45","unstructured":"Jiang W Omega 3 for treatment of depression in patients with heart failure (OCEAN) ClinicalTrials.gov\/show\/NCT02057406"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0046|cit46","unstructured":"Kamath J Omega 3 FA supplements as augmentation in the treatment of depression ClinicalTrials.gov\/show\/NCT01803711"},{"issue":"8","key":"10.1002\/14651858.CD004692.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.4088\/JCP.10m05966blu","article-title":"The efficacy of omega-3 supplementation for major depression: A randomized controlled trial [ISRCTN47431149]","volume":"72","author":"Lesp\u00e9rance","year":"2011","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0048|cit48","unstructured":"Lesp\u00e9rance F Double-blind, placebo-controlled, randomised trial of eicosapentaenoic acid (EPA) for major depression www.controlled-trials.com\/ISRCTN47431149\/"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3945\/ajcn.2008.26749","article-title":"Ethyl-eicosapentaenoic acid for the treatment of psychological distress and depressive symptoms in middle-aged women: a double-blind, placebo-controlled, randomized clinical trial","volume":"89","author":"Lucas","year":"2009","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0050|cit50","unstructured":"Lucas M Double-blind, placebo-controlled, randomised, clinical trial of eicosapentaenoic acid in the treatment of mood disorders among middle-aged women www.controlled-trials.com\/ISRCTN69617477"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","article-title":"A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression","volume":"160","author":"Marangell","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0052|cit52","unstructured":"Marangell LB Zboyan HA Cress KK Benisek D Arterburn L A double-blind, placebo-controlled study of docosahexaenoic acid (DHA) in the treatment of depression 4th Congress of the International Society for the Study of Lipids and Fatty Acids, Tsukuba, Japan"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0053|cit53","unstructured":"Comperssion with the combined effects of omega _3 and citalopram for depression during menopause in postmenopausal women referred to health centers in Hamadan city in 1391: a double-blind clinical trial IRCT2013052113405N1"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub5-BIB0054|cit54","first-page":"QC01","article-title":"Effect of citalopram in combination with omega-3 on depression in post-menopausal women: a triple blind randomized controlled trial","volume":"10","author":"Masoumi","year":"2016","journal-title":"Journal of Clinical and Diagnostic Research: JCDR"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0055|cit55","unstructured":"Lanct\u00f4t K Hermann N Treating depression in coronary artery disease with omega-3 fatty acids ClinicalTrials.gov\/show\/NCT00981383"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bbi.2016.10.005","article-title":"Oxidative stress predicts depressive symptom changes with omega-3 fatty acid treatment in coronary artery disease patients","volume":"60","author":"Mazereeuw","year":"2017","journal-title":"Brain, Behavior, and Immunity"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/JCP.0000000000000565","article-title":"Omega-3 fatty acids, depressive symptoms, and cognitive performance in patients with coronary artery disease: analyses from a randomized, double-blind, placebo-controlled trial","volume":"36","author":"Mazereeuw","year":"2016","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0058|cit58","unstructured":"Mazereeuw G Omega-3 fatty acids and depressive symptoms in coronary artery disease Dissertation Abstracts International: Section B: The Sciences and Engineering 2017 8 B(E)"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0059|cit59","unstructured":"Mischoulon D Nierenberg AA Schettler PJ Kinkead B Fehling K Martinson M Clinical predictors of response to omega-3 fatty acids in major depressive disorder [abstract] Biological Psychiatry [abstracts of the 70th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP; 2015 May 14 - 16;Toronto, ON Canada] 2015 147S"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4088\/JCP.14m08986","article-title":"A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression","volume":"76","author":"Mischoulon","year":"2015","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0061|cit61","first-page":"S46","article-title":"Depression, inflammation, and omega-3 fatty acids","volume":"Suppl 1","author":"Mischoulon","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0062|cit62","unstructured":"Mischoulon D Omega-3 fatty acids for treatment of major depression: differential effects of EPA and DHA, and associated biochemical and immune parameters ClinicalTrials.gov\/ct2\/show\/NCT00361374"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0063|cit63","unstructured":"Rapaport MH Mischoulon D Omega-3 fatty acids for treatment of major depression: differential effects of EPA and DHA, and associated biochemical and immune parameters ClinicalTrials.gov\/ct2\/show\/NCT00517036"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0064|cit64","doi-asserted-by":"crossref","unstructured":"Rapaport MH Nierenberg AA Schettler PJ Kinkead B Cardoos A Walker R Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study Molecular Psychiatry 2016 21 1 71 9","DOI":"10.1038\/mp.2015.22"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0065|cit65","unstructured":"Rapaport MH Schettler P Pace TW Kinkead B Nierenberg AA Mischoulon D Inflammation, depression and N-3 fatty acids: a case of personalized medicine abstract Neuropsychopharmacology [abstracts of the 52nd Annual Meeting of the American College of Neuropsychopharmacology, ACNP; 2013 Dec 8 - 12; Hollywood, FL United States] 2013 S353 S4"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0066|cit66","unstructured":"Rapaport MH Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder [abstract] Biological Psychiatry [abstracts of the 70th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP; 2015 May 14 - 16; Toronto, ON Canada] 2015 146S 7S"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0067|cit67","first-page":"S46","article-title":"Depression, inflammation, and omega-3 fatty acids","volume":"suppl 1","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0068|cit68","unstructured":"Mischoulon D Nierenberg AA Schettler PJ Kinkead B Fehling K Martinson M Clinical predictors of response to omega-3 fatty acids in major depressive disorder [abstract] Biological Psychiatry [abstracts of the 70th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP; 2015 May 14 - 16;Toronto, ON Canada] 2015 147S"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4088\/JCP.14m08986","article-title":"A double-blind, randomized controlled clinical trial comparing eicosapentaenoic acid versus docosahexaenoic acid for depression","volume":"76","author":"Mischoulon","year":"2015","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0070|cit70","unstructured":"Mischoulon D Omega-3 fatty acids for treatment of major depression: differential effects of EPA and DHA, and associated biochemical and immune parameters ClinicalTrials.gov\/ct2\/show\/NCT00361374"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0071|cit71","unstructured":"Rapaport MH Mischoulon D Omega-3 fatty acids for treatment of major depression: differential effects of EPA and DHA, and associated biochemical and immune parameters ClinicalTrials.gov\/ct2\/show\/NCT00517036"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0072|cit72","doi-asserted-by":"crossref","unstructured":"Rapaport MH Nierenberg AA Schettler PJ Kinkead B Cardoos A Walker R Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study Molecular Psychiatry 2016 21 71 9","DOI":"10.1038\/mp.2015.22"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0073|cit73","unstructured":"Rapaport MH Schettler P Pace TW Kinkead B Nierenberg AA Mischoulon D Inflammation, depression and N-3 fatty acids: a case of personalized medicine abstract Neuropsychopharmacology [abstracts of the 52nd Annual Meeting of the American College of Neuropsychopharmacology, ACNP; 2013 Dec 8 - 12; Hollywood, FL United States] 2013 S353 S4"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0074|cit74","unstructured":"Rapaport MH Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder [abstract] Biological Psychiatry [abstracts of the 70th Annual Scientific Convention and Meeting of the Society of Biological Psychiatry, SOBP; 2015 May 14 - 16; Toronto, ON Canada] 2015 146S 7S"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0075|cit75","first-page":"3","article-title":"Omega-3 fatty acid effective as monotherapy for MDD","volume":"20","year":"2009","journal-title":"Brown University Psychopharmacology Update"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4088\/JCP.08m04603","article-title":"A double-blind, randomized controlled trial of ethyl-eicosapentaenoate for major depressive disorder [NCT00096798]","volume":"70","author":"Mischoulon","year":"2009","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0077|cit77","unstructured":"Mischoulon D Ethyl eicosapentanoic acid (Ethyl-EPA) for treating major depression ClinicalTrials.gov\/show\/NCT00096798"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD004692.pub5-BIB0079|cit79","first-page":"149","article-title":"Omega-3 fatty acid treatment of depressive breakthrough during unipolar maintenance","volume":"5","author":"Nemets","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD004692.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/S0924-977X(02)80141-9","article-title":"Omega-3 fatty acid treatment of depressive breakthrough during unipolar maintenance","volume":"12","author":"Stahl","year":"2002","journal-title":"European Neuropsychopharmacology"},{"issue":"2-3","key":"10.1002\/14651858.CD004692.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000377640","article-title":"Supplementation of n-3 polyunsaturated fatty acids for major depressive disorder: A randomized, double-blind, 12-week, placebo-controlled trial in Korea","volume":"66","author":"Park","year":"2015","journal-title":"Annals of Nutrition & Metabolism"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0082|cit82","unstructured":"Park Y Omega-3 index as a risk factor for depression in Korean and effect of Omega-3 fatty acids on Korean patients with depression [KCT0001206] cris.nih.go.kr\/cris\/en\/search\/search_result_st01.jsp?seq=4315"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.","volume":"59","author":"Peet","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub5-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.","volume":"59","author":"Peet","year":"2002","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1475-2891-11-82","article-title":"Comparison between the AA\/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters","volume":"11","author":"Rizzo","year":"2012","journal-title":"Nutrition Journal"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1080\/07315724.2010.10719817","article-title":"Effect of omega-3 fatty acids supplementation on depressive symptoms and on health-related quality of life in the treatment of elderly women with depression: a double-blind, placebo-controlled, randomized clinical trial","volume":"29","author":"Rondanelli","year":"2010","journal-title":"Journal of the American College of Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12603-011-0011-y","article-title":"Long chain omega 3 polyunsaturated fatty acids supplementation in the treatment of elderly depression: effects on depressive symptoms, on phospholipids fatty acids profile and on health-related quality of life","volume":"15","author":"Rondanelli","year":"2011","journal-title":"Journal of Nutrition, Health & Aging"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1179\/1476830511Y.0000000032","article-title":"Effects of a diet integration with an oily emulsion of DHA-phospholipids containing melatonin and tryptophan in elderly patients suffering from mild cognitive impairment","volume":"15","author":"Rondanelli","year":"2012","journal-title":"Nutritional Neuroscience"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"e0147195","DOI":"10.1371\/journal.pone.0147195","article-title":"Omega-3 fatty acids for depression in multiple sclerosis: a randomized pilot study","volume":"11","author":"Shinto","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0091|cit91","unstructured":"Shinto L Fish oil for the treatment of depression in patients with multiple sclerosis ClinicalTrials.gov\/show\/NCT00122954"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0092|cit92","first-page":"22","article-title":"Adjunctive fish oil for depression","volume":"29","year":"2005","journal-title":"Nurses' Drug Alert"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.plefa.2004.11.004","article-title":"Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression","volume":"72","author":"Silvers","year":"2005","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.euroneuro.2003.10.001","article-title":"Corrigendum to \"Omega-3 fatty acids in major depressive disorder A preliminary double-blind, placebo-controlled trial\" [Eur Neuropsychopharmacol. 13 (2003) 267-71]","volume":"14","author":"Su","year":"2004","journal-title":"European Neuropsychopharmacology"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0924-977X(03)00032-4","article-title":"Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial","volume":"13","author":"Su","year":"2003","journal-title":"European Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0096|cit96","unstructured":"Study of supplementation of antidepressants with fish oil to improve time to clinical response (SADFAT) clinicaltrials.gov\/ct2\/show\/NCT00963196"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0097|cit97","unstructured":"Comparison of the effect of eicosapentaenoic acid and docosahexaenoic acid on the treatment of depression Irct201010054873N"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0098|cit98","unstructured":"Randomized double-blind study to evaluate the adjuvant effect of polyunsaturated fatty acids omega-3 in therapy with SSRI paroxetine mesylate in unipolar mood depression and recurrent depression www.ClinicalTrialsregister.eu\/ctr-search\/trial\/2006-004949-41\/IT"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0099|cit99","first-page":"S75","article-title":"A comparative study of addition therapy of choline alfoscerate and omega 3 fatty acid in older depressed patients with or without executive dysfunction","volume":"25","author":"Kwak","year":"2014","journal-title":"International Psychogeriatrics"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0100|cit100","unstructured":"Lima L A randomised study on the antidepressive effect of fluoxetine and folic acid, as possible augmenter, and the SYNThesis of serotonin (5-HT) in lymphocytes prior and after treatment isrctn.org\/ISRCTN06123818"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0101|cit101","unstructured":"A multicentre, double-blind, randomised, parallel group, placebo-controlled, dose ranging pilot study of ethyl eicosapentaenoate (EPA) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy ISRCTN44366049"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0102|cit102","unstructured":"A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of LAX-101 (ethyl eicosapentaenoate [EPA]) in patients with a new or recurrent episode of depression ISRCTN63565713"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0103|cit103","unstructured":"A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of LAX-101 (ethyl eicosapentaenoate [EPA]) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy ISRCTN38354847"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0104|cit104","unstructured":"Murck H A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of Lax-101 (ethyl eicosapentaenoate) as adjunct therapy in patients who remain depressed following treatment with standard antidepressant therapy National Research Register 2004"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0105|cit105","unstructured":"Naqvi S Treating adolescent depression with fish oils ClinicalTrials.gov\/show\/NCT00658476"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0106|cit106","unstructured":"The effect of fish oil in major depressive disorder ClinicalTrials.gov\/show\/NCT00816322"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0107|cit107","unstructured":"Su KP The effect of fish oil in major depressive disorder ClinicalTrials.gov\/show\/NCT01371383"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0108|cit108","unstructured":"Amminger GP Rice S Youth Depression Alleviation: a randomised controlled trial of omega-3 fatty acids (fish oil) for major depressive disorder in young people (YoDA-F) www.anzctr.org.au\/ACTRN12613001352796.aspx"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0109|cit109","doi-asserted-by":"crossref","unstructured":"Rice SM Hickie IB Yung AR Mackinnon A Berk M Davey C Youth depression alleviation: the Fish Oil Youth Depression Study (YoDA-F): A randomized, double-blind, placebo-controlled treatment trial Early Intervention in Psychiatry 2016 10 290 9","DOI":"10.1111\/eip.12166"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0110|cit110","unstructured":"Folic acid and omega -3 fatty acid supplementation in depressed older adults NCT00480207"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0111|cit111","unstructured":"Fish oil as adjunct treatment for major depressive disorder NCT03295708"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0112|cit112","unstructured":"Fish oil supplementation in late-life depression NCT01235533"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0113|cit113","unstructured":"Study on the effect of PRKCB1 modulating inflammatory factors and the role for developing major depressive disorder NCT03899194"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0114|cit114","unstructured":"Howe P Fish oil treatment for depression in cardiovascular disease www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=82950"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cct.2016.02.002","article-title":"Design and methods for the Better Resiliency Among Veterans and non-Veterans with Omega-3's (BRAVO) study: a double blind, placebo-controlled trial of omega-3 fatty acid supplementation among adult individuals at risk of suicide","volume":"47","author":"Marriott","year":"2016","journal-title":"Contemporary Clinical Trials"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0116|cit116","unstructured":"Marriott BP The Better Resiliency Among Veterans With Omega-3's (BRAVO) Study NCT01901887"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD004692.pub5-BIB0117|cit117","first-page":"S487","article-title":"Comparison of the implicit association test with established clinical rating scales in suicide risk assessment: Baseline data from the better resiliency among veterans and non-veterans with omega-3 s (BRAVO) study","volume":"41","author":"Tolliver","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0118|cit118","unstructured":"Nakano W Augmentation of omega-3 fatty acid with antidepressants for major depressive disorder: a double-blind, randomized controlled trial apps.who.int\/trialsearch\/Trial.aspx?TrialID=JPRN-UMIN000013525"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0119|cit119","unstructured":"Parker GB A study of omega-3 as an augmentor of antidepressant treatment for major depression ClinicalTrials.gov\/show\/NCT00289484"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0120|cit120","unstructured":"Piperoglou M Adjunctive natural low dose docosahexaenoic acid (DHA) omega-3 in a 16 week random double-blind placebo controlled (RDBPC) cross-over withdrawal study in a group of chronic, psychiatric out-patients with anxiety and mood disorders www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?id=365804"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"102219","DOI":"10.1016\/j.plefa.2020.102219","article-title":"Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation","volume":"164","author":"Lamon-Fava","year":"2021","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"issue":"Supplement","key":"10.1002\/14651858.CD004692.pub5-BIB0122|cit122","first-page":"434","article-title":"A molecular rationale for n-3 PUFA augmentation of antidepressant action","volume":"44","author":"Rapaport","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0123|cit123","unstructured":"Rapaport MH Omega-3 fatty acids for major depressive disorder with high inflammation: a personalized approach NCT02553915"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0124|cit124","first-page":"152","article-title":"Effect of omega-3 fatty acids versus 5-hydroxytryptophan as add on therapy to sertraline in controlling suicidal ideation in patients with depression: a comparative study","volume":"6","author":"Sahoo","year":"2016","journal-title":"International Journal of Pharmacological Research"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0125|cit125","first-page":"131","article-title":"Effect of omega-3 fatty acids vs 5-hydroxytryptophan as add on therapy in controlling suicidal ideation","volume":"Suppl 1","author":"Singh","year":"2015","journal-title":"Indian Journal of Physiology and Pharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0126|cit126","unstructured":"Smith D An 8 week randomised, double-blind, placebo controlled trial investigating the role of adjunctive bioactive lipids specifically; docosahexaenoic acid (DHA) versus eicosapentaenoic acid (EPA) in major depressive disorder - with a 6 week open label extension of DHA in patients aged 18 - 65 years www.anzctr.org.au\/Trial\/Registration\/TrialReview.aspx?ACTRN=12610000710022"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0127|cit127","unstructured":"The effect of transcranial direct current stimulation (tDCS) and omega-3 supplementation on depression and weight Irct20200716048117N"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0128|cit128","unstructured":"Role of omega 3 fatty acid in etiopathogenesis of depression and trial of two drugs: flax seed oil and Ashwagnadharishta in its management CTRI\/2020\/10\/028383"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0129|cit129","unstructured":"Yao JK Coronary artery disease (CAD) risk in schizophrenia: effect of omega-3 fatty acid supplementation ClinicalTrials.gov\/show\/NCT00167310"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0130|cit130","unstructured":"Role of omega-3 polyunsaturated fatty acid in the management of major depressive disorder NCT03732378"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0131|cit131","unstructured":"Abedi P The impact of omega-3 fatty acids on depression of menopausal women: a randomized double-blind clinical trial Climacteric 2014 63"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"738-43","DOI":"10.1177\/0269881111424928","article-title":"Effects of omega-3 fatty acid supplementation on mood and emotional information processing in recovered depressed individuals","volume":"26","author":"Antypa","year":"2012","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0133|cit133","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and Statistical Manual of Mental Disorders, 5th Edition","author":"American Psychiatric Association","year":"2013"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub5-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/ajcn\/84.6.1308","article-title":"Effects of n3 long chain polyunsaturated fatty acids on depressed mood: systematic review of published trials","volume":"84","author":"Appleton","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub5-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00127-006-0142-3","article-title":"Depressed mood and n-3 polyunsaturated fatty acid intake from fish: non-linear or confounded association?","volume":"42","author":"Appleton","year":"2007","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub5-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.plefa.2008.04.009","article-title":"No clear evidence of an associations between plasma concentrations of n-3 long chain polyunsaturated fatty acids and depressed mood in a non-clinical population","volume":"78","author":"Appleton","year":"2008","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0137|cit137","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S0954422408998620","article-title":"Is there a role for n-3 long-chain polyunsaturated fatty acids in the regulation of mood and behaviour? A review of the evidence to date from epidemiological studies, clinical studies and intervention trials","volume":"21","author":"Appleton","year":"2008","journal-title":"Nutrition Research Reviews"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3945\/ajcn.2009.28313","article-title":"Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood","volume":"91","author":"Appleton","year":"2010","journal-title":"American Journal of Clinical Nutrition"},{"issue":"6 suppl","key":"10.1002\/14651858.CD004692.pub5-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of n-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"American Journal of Clinical Nutrition"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nutres.2017.10.013","article-title":"Systematic review and meta-analysis of omega-3-fatty acids in elderly patients with depression","volume":"50","author":"Bae","year":"2018","journal-title":"Nutrition Research"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"21-32","DOI":"10.1136\/jnnp-2019-320912","article-title":"Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials","volume":"91","author":"Bai","year":"2020","journal-title":"Journal of Neurology, Neurosurgery & Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0142|cit142","doi-asserted-by":"crossref","first-page":"e975","DOI":"10.1038\/tp.2016.243","article-title":"The efficacy of fish oil supplements in the treatment of depression: food for thought","volume":"6","author":"Bastiaansen","year":"2016","journal-title":"Translational Psychiatry\u00a0"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0143|cit143","volume-title":"Beck Depression Inventory Manual","author":"Beck","year":"1987"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0144|cit144","volume-title":"BNF Briefing paper: n-3 fatty acids and health","author":"British Nutrition Foundation","year":"1999"},{"issue":"2-3","key":"10.1002\/14651858.CD004692.pub5-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2005.10.009","article-title":"Fish consumption in pregnancy and omega-3 status after birth are not associated with postnatal depression","volume":"90","author":"Browne","year":"2006","journal-title":"Journal of Affective Disorders"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s11745-003-1068-y","article-title":"n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic","volume":"38","author":"Calder","year":"2003","journal-title":"Lipids"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/ajcn\/63.1.116","article-title":"The effect on human tumor necrosis factor alpha and interleukin 1B production of diets enriched in n-3 fatty acids from vegetable oil or fish oil","volume":"63","author":"Caughey","year":"1996","journal-title":"American Journal of Clinical Nutrition"},{"issue":"4-5","key":"10.1002\/14651858.CD004692.pub5-BIB0148|cit148","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.plefa.2006.07.005","article-title":"Omega-3 fatty acids and monoamine neurotransmission","volume":"75","author":"Chalon","year":"2006","journal-title":"Prostaglandins, Leukotrienes, and Essential Fatty Acids"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"113652","DOI":"10.1016\/j.psychres.2020.113652","article-title":"Efficacy of omega-3 supplementation on sertraline continuous therapy to reduce depression or anxiety symptoms: a systematic review and meta-analysis","volume":"296","author":"Chambergo-Michilot","year":"2021","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0150|cit150","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00005053-199805000-00007","article-title":"Use of the Center for Epidemiological Studies Depression (CES-D) scale in Korea","volume":"186","author":"Cho","year":"1998","journal-title":"Journal of Nervous and Mental Disease"},{"issue":"10128","key":"10.1002\/14651858.CD004692.pub5-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0152|cit152","unstructured":"Covidence systematic review software Veritas Health Innovation. Available at www.covidence.org 2021"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/9780470693926.ch15","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Deeks","year":"2001"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub5-BIB0154|cit154","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1093\/jn\/129.11.2088","article-title":"Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula fed piglets","volume":"129","author":"De la Presa Owens","year":"1999","journal-title":"Journal of Nutrition"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/jn\/124.12.2466","article-title":"Chronic dietary alpha-linolenic acid deficiency alters dopaminergic and serotonergic neurotransmission in rats","volume":"124","author":"Delion","year":"1994","journal-title":"Journal of Nutrition"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1046\/j.1471-4159.1996.66041582.x","article-title":"Alpha-linolenic acid dietary deficiency alters age related changes in dopaminergic and serotonergic neurotransmission in the rat frontal cortex","volume":"66","author":"Delion","year":"1996","journal-title":"Journal of Neurochemistry"},{"issue":"8","key":"10.1002\/14651858.CD004692.pub5-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1176\/ajp.150.8.1246","article-title":"Three concommitants: personality disorders, psychiatric severity, and outcome of dynamic psychotherapy of major depression","volume":"150","author":"Diguer","year":"1993","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0158|cit158","first-page":"170","volume-title":"Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies","author":"Dupuy","year":"1984"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0159|cit159","doi-asserted-by":"crossref","first-page":"s142","DOI":"10.1042\/bst026s142","article-title":"Depletion of docosahexaenoic acid in red blood cell membranes of depressive patients","volume":"26","author":"Edwards","year":"1998","journal-title":"Biochemical Society Transactions"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/9780470693926.ch2","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Egger","year":"2001"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub5-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0009-3084(90)90063-W","article-title":"A comparison of the effects of linolenic acid (18:3 omega 3) and docosahexaenoic (22:6 omega 3) acids on phospholipid bilayers","volume":"54","author":"Ehringer","year":"1990","journal-title":"Chemistry and Physics of Lipids"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub5-BIB0162|cit162","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacology Bulletin"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0163|cit163","doi-asserted-by":"crossref","first-page":"308-24","DOI":"10.1002\/wps.20672","article-title":"The efficacy and safety of nutrient supplements in the treatment of mental disorders: a meta-review of meta-analyses of randomized controlled trials","volume":"18","author":"Firth","year":"2019","journal-title":"World Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Min-mental state\": a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1744-859X-12-26","article-title":"No role for initial severity on the efficacy of antidepressants: results of a multi-meta-analysis","volume":"12","author":"Fountoulakis","year":"2013","journal-title":"Annals of General Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1192\/bjp.188.1.46","article-title":"Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study","volume":"188","author":"Frangou","year":"2006","journal-title":"British Journal of Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD004692.pub5-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jad.2007.12.228","article-title":"Omega-3 fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo-controlled study","volume":"110","author":"Freeman","year":"2008","journal-title":"Journal of Affective Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jclinepi.2005.06.006","article-title":"Imputing missing standard deviations in meta-analyses can provide accurate results","volume":"59","author":"Furukawa","year":"2006","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0169|cit169","first-page":"17m11596","article-title":"A double-blind placebo-controlled trial of omega-3 fatty acids as a monotherapy for adolescent depression","volume":"79","author":"Gabbay","year":"2018","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1192\/bjp.bp.105.019562","article-title":"Lipids and essential fatty acids in patients presenting with self-harm","volume":"190","author":"Garland","year":"2007","journal-title":"British Journal of Psychiatry"},{"issue":"10159","key":"10.1002\/14651858.CD004692.pub5-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub5-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.3945\/ajcn.111.018259","article-title":"Effects of n-3 fatty acids on depressivesymptoms and dispositional optimism after myocardial infarction","volume":"94","author":"Giltay","year":"2011","journal-title":"American Journal of Clinical Nutrition"},{"issue":"1-2","key":"10.1002\/14651858.CD004692.pub5-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.psychres.2015.05.072","article-title":"Short-term supplementation of long-chain omega-3 polyunsaturated fatty acids reduces depression symptomology among young adults with depression: A preliminary randomized, double blind, and placebo controlled trial","volume":"229","author":"Ginty","year":"2015","journal-title":"Psychiatry Research"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0174|cit174","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/mp.2016.3","article-title":"A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression","volume":"21","author":"Goldsmith","year":"2016","journal-title":"Molecular Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0175|cit175","volume-title":"National Diet and Nutritional Survey of British Adults","author":"Gregory","year":"2000"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0176|cit176","doi-asserted-by":"crossref","first-page":"e96905","DOI":"10.1371\/journal.pone.0096905","article-title":"Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials","volume":"9","author":"Grosso","year":"2014","journal-title":"PloS ONE"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0177|cit177","volume-title":"Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology, revised","author":"Guy","year":"1976"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/070674370304800308","article-title":"Essential fatty acids and the brain","volume":"48","author":"Haag","year":"2003","journal-title":"Canadian Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1176\/appi.ajp.161.3.567","article-title":"Is dietary intake of omega-3 fatty acids associated with depression?","volume":"161","author":"Hakkarainen","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1192\/bjp.bp.106.022707","article-title":"Omega-3 fatty acid supplementation in patients with recurrent self-harm. Single-centre double blind randomised controlled trial","volume":"190","author":"Hallahan","year":"2007","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1192\/bjp.bp.114.160242","article-title":"Efficacy of omega-3 highly unsaturatedfatty acids in the treatment of depression","volume":"209","author":"Hallahan","year":"2016","journal-title":"British Journal of Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD004692.pub5-BIB0182|cit182","doi-asserted-by":"crossref","first-page":"e028527","DOI":"10.1136\/bmjopen-2018-028527","article-title":"Complementary therapies for clinical depression: an overview of systematic reviews","volume":"9","author":"Haller","year":"2019","journal-title":"BMJ Open"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub5-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.nut.2004.07.020","article-title":"Effects of w-3 fatty acid-containing phospholipids on blood catecholamine concentrations in healthy volunteers: a randomized, placebo controlled, double blind trial","volume":"21","author":"Hamazaki","year":"2005","journal-title":"Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"9110","key":"10.1002\/14651858.CD004692.pub5-BIB0185|cit185","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(05)79168-6","article-title":"Fish consumption and major depression","volume":"351","author":"Hibbeln","year":"1998","journal-title":"Lancet"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub5-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD004692.pub5-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0188|cit188","unstructured":"Higgins JP Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from training.cochrane.org\/handbook\/archive\/v5.1\/"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub5-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1176\/ajp.161.10.1922","article-title":"Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder","volume":"161","author":"Hirashima","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.medici.2016.05.003","article-title":"The importance of n-6\/n-3 fatty acids ratio in the major depressive disorder","volume":"52","author":"Husted","year":"2016","journal-title":"Medicina"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12916-017-0791-y","article-title":"A randomised controlled trial of dietary improvement for adults with major depression (the \u2018SMILES\u2019 trial)","volume":"15","author":"Jacka","year":"2017","journal-title":"BMC Medicine\u00a0"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD004692.pub5-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"343s","DOI":"10.1093\/ajcn\/71.1.343S","article-title":"Dietary polyunsaturated fatty acids and inflammatory mediator production","volume":"71","author":"James","year":"2000","journal-title":"American Journal of Clinical Nutrition"},{"issue":"9","key":"10.1002\/14651858.CD004692.pub5-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.3390\/ijms22094393","article-title":"Disentangling the molecular mechanisms of the antidepressant activity of omega-3 polyunsaturated fatty acid: a comprehensive review of the literature","volume":"22","author":"Kalkman","year":"2021","journal-title":"International Journal of Molecular Sciences"},{"issue":"9","key":"10.1002\/14651858.CD004692.pub5-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","article-title":"Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder","volume":"60","author":"Mintz","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.clnesp.2018.03.001","article-title":"Omega-3 supplementation effects on body weight and depression among dieter women with co-morbidity of depression and obesity compared with the placebo: a randomized clinical trial","volume":"25","author":"Keshavarz","year":"2018","journal-title":"Clinical Nutrition ESPEN"},{"issue":"5-6","key":"10.1002\/14651858.CD004692.pub5-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1024\/0300-9831\/a000249","article-title":"Are supplementation of omega-3 and ascorbic acid effective in reducing oxidative stress and depression among depressed shift workers?","volume":"85","author":"Khajehnasiri","year":"2015","journal-title":"International Journal for Vitamin and Nutrition Research"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub5-BIB0198|cit198","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1371\/journal.pmed.0050045","article-title":"Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration","volume":"5","author":"Kirsch","year":"2008","journal-title":"PLoS Medicine"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0199|cit199","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jad.2019.08.018","article-title":"Treatments for depression: Side effects, adverse events and health risks","volume":"259","author":"Kirsch","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/acps.12698","article-title":"Peripheral cytokine and chemokine alterations in depression: a meta-analysis of 82 studies","volume":"135","author":"K\u00f6hler","year":"2017","journal-title":"Acta Psychiatrica Scandinavica\u00a0"},{"issue":"9","key":"10.1002\/14651858.CD004692.pub5-BIB0201|cit201","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41398-019-0515-5","article-title":"Efficacy of omega-3 PUFAs in depression: a meta-analysis","volume":"9","author":"Liao","year":"2019","journal-title":"Translational Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004692.pub5-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.4088\/JCP.v68n0712","article-title":"A meta-analytic review of double-blind, placebo-controlled trials of anti-depressant efficacy of omega-3 fatty acids","volume":"68","author":"Lin","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/mp.2012.111","article-title":"Are omega-3 fatty acids anti-depressants or just mood-improving agents?","volume":"17","author":"Lin","year":"2012","journal-title":"Molecular Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ajcn\/62.3.572","article-title":"Short- and long-term repeatability of fatty acid composition of human plasma phospholipids and cholesterol esters: The Atherosclerosis Risk in Communities (ARIC) Study Investigators","volume":"62","author":"Ma","year":"1995","journal-title":"American Journal of Clinical Nutrition"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1054\/plef.2002.0435","article-title":"Depression and adipose essential polyunsaturated fatty acids","volume":"67","author":"Mamalakis","year":"2002","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.plefa.2004.04.002","article-title":"Depression and adipose polyunsaturated fatty acids in an adolescent group","volume":"71","author":"Mamalakis","year":"2004","journal-title":"Prostaglandins, Leukotriens and Essential Fatty Acids"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub5-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.pbb.2006.10.008","article-title":"Depression and serum adiponectin and adipose omega-3 and omega-6 fatty acids in adolescents","volume":"85","author":"Mamalakis","year":"2006","journal-title":"Pharmacology, Biochemistry and Behavior"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0005-2760(93)90049-F","article-title":"Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout","volume":"1210","author":"Marangoni","year":"1993","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0210|cit210","first-page":"188","article-title":"EPA but not DHA appears to be responsible for the efficacy of omega-3 LC-PUFA supplementation in depression: evidence from an updated meta-analysis of randomized controlled trials","volume":"18","author":"Martins","year":"2011","journal-title":"OCL - Oleagineux Corps Gras Lipides"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0211|cit211","first-page":"575","article-title":"Long chain n-3 fatty acids improve depression syndrome in type 2 diabetes mellitus","volume":"47","author":"Mazaherioun","year":"2018","journal-title":"Iranian Journal of Public Health"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0212|cit212","first-page":"146S","article-title":"Omega-3 fatty acid deficiency decreases dopamine D2 receptor binding and increases serotonin 5-HT2A receptor binding in the adult rat prefrontal cortex","volume":"59","author":"McNamara","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nri.2015.5","article-title":"The role of inflammation in depression: from evolutionary imperative to modern treatment target","volume":"16","author":"Miller","year":"2016","journal-title":"Nature Reviews Immunology"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0214|cit214","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1017\/S0033291706008701","article-title":"Risk of postpartum depression in relation to dietary fish and fat intake in Japan: the Osaka Maternal and Child Health Study","volume":"36","author":"Miyake","year":"2006","journal-title":"Psychological Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1038\/tp.2016.29","article-title":"Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder","volume":"6","author":"Mocking","year":"2016","journal-title":"Translational Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"British Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004692.pub5-BIB0217|cit217","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.euroneuro.2012.08.003","article-title":"Eicosapentaenoic acid versus docosahexaenoic acid in mild-to-moderate depression: a randomized, double-blind, placebo-controlled trial","volume":"23","author":"Mozaffari-Khosravi","year":"2013","journal-title":"European Neuropsychopharmacology\u00a0"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2045125319869791","article-title":"Trim the fat: the role of omega-3 fatty acids in psychopharmacology","volume":"9","author":"Nasir","year":"2019","journal-title":"Therapeutic Advances in Psychopharmacology"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub5-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1176\/ajp.2006.163.6.1098","article-title":"Omega-3 treatment of childhood depression: a controlled, double-blind pilot study","volume":"163","author":"Nemets","year":"2006","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0220|cit220","volume-title":"Depression: Management of Depression in Primary and Secondary Care","author":"National Institute for Clinical Excellence","year":"2004"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1176\/appi.ajp.160.12.2222","article-title":"Cross-national comparisons of seafood consumption and rates of bipolar disorders","volume":"160","author":"Noaghiul","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12991-018-0220-4","article-title":"Effect of fish oil omega-3 fatty acids on reduction of depressive symptoms among HIV-seropositive pregnant women: a randomized, double-blind controlled trial","volume":"17","author":"Opiyo","year":"2018","journal-title":"Annals of General Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub5-BIB0223|cit223","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1176\/ajp.2006.163.6.969","article-title":"Omega-3 fatty acids and mood disorders","volume":"163","author":"Parker","year":"2006","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004692.pub5-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/1028415X.2017.1411320","article-title":"A Mediterranean-style dietary intervention supplemented with fish oil improves diet quality and mental health in people with depression: a randomized controlled trial (HELFIMED)","volume":"22","author":"Parletta","year":"2019","journal-title":"Nutritional Neuroscience"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(97)00206-0","article-title":"Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients","volume":"43","author":"Peet","year":"1998","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1192\/bjp.184.5.404","article-title":"International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis","volume":"184","author":"Peet","year":"2004","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","article-title":"A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers","volume":"70","author":"Raison","year":"2013","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub5-BIB0228|cit228","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0021-9150(02)00427-6","article-title":"Dietary alpha-linolenic acid decreases C-reactive protein, serum amyloid A and interleukin-6 in dyslipidaemic patients","volume":"167","author":"Rallidis","year":"2003","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0229|cit229","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/mp.2015.22","article-title":"Inflammation as a predictive biomarker for response to omega-3 fatty acids in major depressive disorder: a proof-of-concept study","volume":"21","author":"Rapaport","year":"2016","journal-title":"Molecular Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub5-BIB0230|cit230","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/1060028016656017","article-title":"Effect of omega-3 fatty acids on depressive symptoms in HIV-positive individuals: a randomized, placebo-controlled clinical trial","volume":"50","author":"Ravi","year":"2016","journal-title":"Annals of Pharmacotherapy"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0231|cit231","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00048670701827267","article-title":"Omega-3 fatty acids as a treatment for perinatal depression: randomized double-blind placebo-controlled trial","volume":"42","author":"Rees","year":"2008","journal-title":"Australian & New Zealand Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0232|cit232","unstructured":"Review Manager (RevMan) The Nordic Cochrane Centre, The Cochrane Collaboration 2020"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0233|cit233","volume-title":"Psychological Assessment Resources","author":"Reynolds","year":"1995"},{"issue":"2","key":"10.1002\/14651858.CD004692.pub5-BIB0234|cit234","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1017\/S0007114507801097","article-title":"No effect of n-3 long chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomized controlled trial","volume":"99","author":"Rogers","year":"2008","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0235|cit235","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1476-511X-6-21","article-title":"Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?","volume":"6","author":"Ross","year":"2007","journal-title":"Lipids in Health and Disease"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0236|cit236","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1079\/NRR200497","article-title":"The impact of long chain n-3 polyunsaturated fatty acids on human health","volume":"18","author":"Ruxton","year":"2005","journal-title":"Nutrition Research Reviews"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0237|cit237","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1037\/0022-3514.69.4.719","article-title":"The structure of psychological well-being revisited","volume":"69","author":"Ryff","year":"1995","journal-title":"Journal of Personality and Social Psychology"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0238|cit238","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jad.2018.11.092","article-title":"Nutraceuticals for major depressive disorder - more is not merrier: an 8-week double-blind, randomised, controlled trial","volume":"245","author":"Sarris","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0239|cit239","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3177\/jnsv.45.655","article-title":"The effect of docosahexaenoic acid on plasma catecholamine concentrations and glucose tolerance during long-lasting psychological stress: a double blind placebo controlled study","volume":"45","author":"Sawazaki","year":"1999","journal-title":"Journal of Nutritional Science and Vitaminology"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub5-BIB0240|cit240","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.euroneuro.2017.07.004","article-title":"Efficacy of adding nutritional supplements in unipolar depression: a systematic review and meta-analysis","volume":"27","author":"Schefft","year":"2017","journal-title":"European Neuropsychopharmacology"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub5-BIB0241|cit241","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011688.pub2","article-title":"Fluoxetine for adults who are overweight or obese","author":"Serralde-Z\u00fa\u00f1iga","year":"2019","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0242|cit242","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1002\/gps.4668","article-title":"The interventional relationship between frequent fish consumption and depression symptoms in aging adults: a randomized controlled trial","volume":"32","author":"Sharifan","year":"2017","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0243|cit243","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1079\/PHN2001308","article-title":"Fish consumption and self-reported physical and mental health status","volume":"5","author":"Silvers","year":"2002","journal-title":"Public Health Nutrition"},{"issue":"5-6","key":"10.1002\/14651858.CD004692.pub5-BIB0244|cit244","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0952-3278(99)80023-4","article-title":"Evoluntionary aspects of omega-3 fatty acids in the food supply","volume":"60","author":"Simopoulos","year":"1999","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub5-BIB0245|cit245","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1017\/S0007114511004788","article-title":"Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial","volume":"107","author":"Sinn","year":"2012","journal-title":"British Journal of Nutrition"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0246|cit246","doi-asserted-by":"crossref","first-page":"14","DOI":"10.5251\/ajfn.2011.1.1.14.27","article-title":"Essential fatty acids and mood: a systematic review of observational studies","volume":"1","author":"Smith","year":"2011","journal-title":"American Journal of Food and Nutrition"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0247|cit247","first-page":"57","article-title":"The role of omega-3 fatty acids in mood disorders","volume":"9","author":"Stahl","year":"2008","journal-title":"Current Opinion in Investigational Drugs"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0248|cit248","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/9780470693926.ch11","volume-title":"Systematic Reviews in Health Care: Meta-analysis in Context","author":"Sterne","year":"2001"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0249|cit249","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega-3 fatty acids in bipolar disorder - a preliminary double-blind, placebo-controlled trial","volume":"56","author":"Stoll","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0250|cit250","doi-asserted-by":"crossref","first-page":"644","DOI":"10.4088\/JCP.v69n0418","article-title":"Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Su","year":"2008","journal-title":"Journal of Clinical Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD004692.pub5-BIB0251|cit251","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.biopsych.2014.01.008","article-title":"Omega-3 fatty acids in the prevention of interferon-alpha-induced depression: results from a randomized, controlled trial","volume":"76","author":"Su","year":"2014","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0252|cit252","first-page":"285S","article-title":"Omega-3 fatty acids for inflammation-related depression","volume":"Suppl 1","author":"Su","year":"2016","journal-title":"Biological Psychiatry"},{"issue":"Part C","key":"10.1002\/14651858.CD004692.pub5-BIB0253|cit253","first-page":"227","article-title":"Eicosapentaenoic and docosahexaenoic acids have different effects on peripheral phospholipase A2 gene expressions in acute depressed patients","volume":"80","author":"Satyanarayanan","year":"2018","journal-title":"Progress in Neuro-Psychopharmacology & Biological Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD004692.pub5-BIB0254|cit254","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.4088\/JCP.10m06634","article-title":"Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression","volume":"72","author":"Sublette","year":"2011","journal-title":"Journal of Clinical Psychiatry Diseases of the Nervous System"},{"issue":"8","key":"10.1002\/14651858.CD004692.pub5-BIB0255|cit255","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00406-011-0191-9","article-title":"The effect of low-dose omega 3 fatty acids on the treatment of mild to moderate depression in the elderly: a double-blind, randomized, placebo-controlled study","volume":"261","author":"Tajalizadekhoob","year":"2011","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"1-2","key":"10.1002\/14651858.CD004692.pub5-BIB0256|cit256","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0166-4328(01)00392-8","article-title":"Influence of a dietary n-3 fatty acid deficiency on the cerebral catecholamine contents, EEG and learning ability in rat","volume":"131","author":"Takeuchi","year":"2002","journal-title":"Behavioral Brain Research"},{"issue":"5","key":"10.1002\/14651858.CD004692.pub5-BIB0257|cit257","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archpsyc.58.5.512","article-title":"Fish consumption, depression, and suicidality in a general population","volume":"58","author":"Tanskanen","year":"2001","journal-title":"Archives of General Psychiatry"},{"issue":"1-2","key":"10.1002\/14651858.CD004692.pub5-BIB0258|cit258","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1023\/A:1006875010120","article-title":"The influence of membrane fluidity, TNF receptor binding, cAMP production and GTPase activity on macrophage cytokine production in rats fed a variety of fat diets","volume":"166","author":"Tappia","year":"1997","journal-title":"Molecular and Cellular Biochemistry"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0259|cit259","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.jad.2018.11.039","article-title":"Omega-3 polyunsaturated fatty acids and psychological intervention for workers with mild to moderate depression: a double-blind randomized controlled trial","volume":"245","author":"Tayama","year":"2019","journal-title":"Journal of Affective Disorders"},{"issue":"10","key":"10.1002\/14651858.CD004692.pub5-BIB0260|cit260","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1002\/mds.20556","article-title":"Quantitative measurements of alternating finger tapping in Parkinson's disease correlate with UPDRS motor disability and reveal the improvement in fine motor control from medication and deep brain stimulation","volume":"20","author":"Taylor","year":"2005","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0261|cit261","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","article-title":"The Inventory of Depressive Symptomology, clinician rating (IDS-C) and self report (IDS-SR), and the Quick Inventory of Depressive Symptomology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders; a psychometric evaluation","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychological Medical"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0262|cit262","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3390\/jpm10040283","article-title":"Brain responses to emotional stimuli after eicosapentaenoic acid and docosahexaenoic acid treatments in major depressive disorder: toward personalized medicine with anti-inflammatory nutraceuticals","volume":"10","author":"Tu","year":"2020","journal-title":"Journal of Personalized Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0263|cit263","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMsa065779","article-title":"Selective publication of antidepressant trials and its influence on apparent efficacy","volume":"358","author":"Turner","year":"2008","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0264|cit264","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/ajcn\/88.3.706","article-title":"Effect of fish-oil supplementation on mental well-being in older subjects: a randomized, double-blind, placebo-controlled trial","volume":"88","author":"Van de Rest","year":"2008","journal-title":"American Journal of Clinical Nutrition"},{"issue":"11","key":"10.1002\/14651858.CD004692.pub5-BIB0265|cit265","doi-asserted-by":"crossref","first-page":"e0241497","DOI":"10.1371\/journal.pone.0241497","article-title":"On the treatment effect heterogeneity of antidepressants in major depression: a Bayesian meta-analysis and simulation study","volume":"15","author":"Volkmann","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0266|cit266","volume-title":"SF-36 Health Survey: Manual and Interpretation Guide","author":"Ware","year":"1993"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0267|cit267","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2190\/U1B0-NKWC-568V-4MAK","article-title":"The 13- and 20-item Hopkins Symptom Checklist Depression Scale: psychometric properties in primary care patients with minor depression or dysthymia","volume":"34","author":"Stellato","year":"2004","journal-title":"International Journal of Psychiatry in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD004692.pub5-BIB0268|cit268","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000501158","article-title":"Clinical efficacy and biological regulations of omega-3 PUFA-derived endocannabinoids in Major Depressive Disorder","volume":"88","author":"Yang","year":"2019","journal-title":"Psychotherapy and Psychosomatics"},{"issue":"3","key":"10.1002\/14651858.CD004692.pub5-BIB0269|cit269","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.plefa.2004.03.011","article-title":"Effects of omega-3 fatty acid on platelet serotonin responsivity in patients with schizophrenia","volume":"71","author":"Yao","year":"2004","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0270|cit270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","article-title":"Development and validation of a geriatric depression screening scale: a preliminary report","volume":"17","author":"Yesavage","year":"1983","journal-title":"Journal of Psychiatric Research"},{"issue":"6","key":"10.1002\/14651858.CD004692.pub5-BIB0271|cit271","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","article-title":"The Hospital Anxiety and Depression Scale","volume":"67","author":"Zigmond","year":"1983","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0272|cit272","unstructured":"Omega-3 fatty acids for depression in adults Cochrane Database of Systematic Reviews 2014 5 10.1002\/14651858.CD004692.pub3"},{"key":"10.1002\/14651858.CD004692.pub5-BIB0273|cit273","unstructured":"Omega-3 fatty acids for depression in adults Cochrane Database of Systematic Reviews 2015 11 10.1002\/14651858.CD004692.pub4"},{"issue":"1","key":"10.1002\/14651858.CD004692.pub5-BIB0274|cit274","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004692.pub2","article-title":"Omega 3 fatty acids for depression","author":"Silvers","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T15:19:17Z","timestamp":1696519157000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD004692.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,11,24]]},"references-count":274,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004692.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,24]]}}}